We are a leading global medicinal cannabis business with world class production assets in Australia and Europe.
Little Green Pharma is one of the most recognisable brands in the European and Australian medical cannabis space.
With world class operations in Denmark and Australia Little Green Pharma now has all the building blocks in place to deliver profitable outcomes.
As a vertically integrated, production capacity, highest quality medicine (EU GMP), presence and strategic positioning in existing and emerging EU markets. we are gaining a strong foothold in the European market.
Having gained the premier brand and first mover advantage, we are now forging ahead to be a front runner across Europe with current sales in Denmark, Germany and the UK. Continuing its early mover strategy into new under supplied markets in Europe Little Green Pharma is one of only a few companies in prime position to do so. France, Italy and Poland are particularly important as there are limited competitors due to high quality standards which we can already meet.
We are passionate about transforming lives for the better and solving real patient problems. With our unwavering commitment to care, we’re consistently developing effective, quality cannabis medicines to make a world a difference for those with chronic conditions.
Little Green Pharma was founded in 2016 with the aims of improving the quality of life for a child debilitated by seizures.
We have pioneered the Australian medical cannabis market and were able to overcome industry hurdles to cultivate and manufacture affordable, natural medication options for treating and relieving a wide range of chronic conditions. And that established our unequivocal quest to continue pioneering quality products we know have the power to make a world of difference.
To date, our success has been driven by our first-mover status – we were the first Australian producer and exporter of cannabis medicines – and our rapid, early entry into key global markets.
We have also produced Denmark’s first locally made cannabis medicine.
Since then, the company has invested significantly into product development, sales and marketing and cultivation capabilities.
We want to improve access to quality cannabis medicines
Our primary goal is to improve patient access to premium cannabis medicines around the world. We do this by operating across the supply chain, from cultivation, manufacturing, distribution, and stakeholder engagement, which allows us to navigate barriers to access and provide our distributors, prescribers, and patients with a seamless end-to-end service for a broad range of cannabis medicines.
Meanwhile, we continue clinical studies into the safety and efficacy of our medicines while developing new and innovative medicinal formulations for our patients.
Little Green Pharma is passionate about delivering quality cannabis medicines we know have the power to make a world of difference.